573 Results (Page 11 of 23)
France Markets Research Reports
France Transdermal Skin Patches Market Analysis
France Transdermal Skin Patches Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Transdermal Skin Patches market is growing globally due to the increasing demand for non-invasive drug delivery, growing prevalence of chronic diseases like cardiovascular disorders, pain management, hormonal imbalances and neurological conditions, geriatric application and pediatric applications of transdermal skin patches due to better patient compliance, advancements in patch technology, expansion of therapeutic applications of transdermal skin patches like hormone replacement therapy, smoking cessation, motion sickness, dermatological conditions, and increasing focus on personalized medicine. Adhex Pharma, ProSolus, Inc, Tapemark, Tesa Tapes Pvt. Ltd., Nitto Denko Corporation, Noven Pharmaceuticals, Inc, LTS Lohmann Therapie-Systeme are the key global market players in transdermal skin patches market.
France Transthyretin Amyloidosis (ATTR) Market Analysis
France Transthyretin Amyloidosis (ATTR) Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Transthyretin Amyloidosis (ATTR) market is growing globally due to the increase in disease awareness, advancements in diagnostic techniques, development of disease-modifying therapies, growing investment in research and development, regulatory support and expedited approvals, collaboration and partnerships between pharmaceutical companies and academic institutions. Pfizer Inc, AstraZeneca, Prothena Corporation plc, Ionis Pharmaceuticals, BELLUS Health Inc , Alnylam Pharmaceuticals, Inc, Eidos Therapeutics, Inc, SOM BIOTECH, Abbvie, Inc., Bausch Health Companies Inc., Bristol Myers Squibb Company, GSK Plc. are the key global market players in transthyretin amyloidosis (ATTR) market.
France Type 1 Diabetes Mellitus Drugs Market Analysis
France Type 1 Diabetes Mellitus Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Type 1 Diabetes Mellitus Drugs market is growing globally due to the rising prevalence of type 1 diabetes mellitus, advancements in insulin therapies, technological advancements in insulin delivery systems, increasing focus on personalized medicine, rising healthcare expenditure, favorable reimbursement policies, increasing patient awareness and education, research and development initiatives and collaborations between pharmaceutical companies and academic institutions. Novo Nordisk, Eli Lilly and Company, Sanofi, Medtronic, Abbott Laboratories, Dexcom, Zealand Pharma, Xeris Pharmaceuticals, Insulet Corporation, and Tandem Diabetes Care are the key global market players in type 1 diabetes mellitus drugs market.
France Type 2 Diabetes Mellitus Drugs Market Analysis
France Type 2 Diabetes Mellitus Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Type 2 Diabetes Mellitus Drugs market is growing globally due to the increasing prevalence of Type 2 diabetes, growing awareness and diagnosis about the disease, advancements in drug therapies, rising geriatric population, government initiatives and healthcare policies, technological advancements in drug delivery, increasing research and development activities and rising healthcare infrastructure. Novo Nordisk, Sanofi, Eli Lilly and Company, Merck & Co., Inc., AstraZeneca, Johnson & Johnson, Boehringer Ingelheim, Takeda Pharmaceutical Company Limited, Bristol-Myers Squibb, Novartis International are the key global market players in type 2 Diabetes Mellitus Drugs Market.
France Tyrosine Kinase Inhibitors Market Analysis
France Tyrosine Kinase Inhibitors Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Tyrosine Kinase Inhibitors market is growing globally due to the Increasing prevalence of cancer, increasing use instead of conventional medicines due to their benefits, including the simplicity of oral administration, the capacity to target various cellular survival pathways, and the surge in demand for novel medications. The market is also influenced by an increase in pharmaceutical company investment and the utilization of cell processes to control different cell activities in cancer. Additionally, the market for tyrosine kinase inhibitors is positively impacted by increase in healthcare spending, awareness, population growth, increased healthcare infrastructure, and improvements in cancer treatments. F. Hoffmann-La Roche Ltd, Takeda Pharmaceutical Company Limited, Ascentage Pharma, AstraZeneca, Eisai Co., Ltd., Novartis AG, Sanofi, Bristol-Myers Squibb Company, Genentech, Inc., Pfizer Inc., Merck & Co., Inc., Suzhou Zelgen Biopharmaceuticals Co., Ltd., Celldex Therapeutics, Exelixis, Inc., Sino Biological Inc., AB Science, Bayer AG Deciphera Pharmaceuticals, Inc., and Johnson & Johnson Services, Inc are the key global market players in tyrosine kinase inhibitors market.
France Ulcerative Colitis Market Analysis
France Ulcerative Colitis Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Ulcerative Colitis market is growing globally due to the increasing prevalence of ulcerative colitis, advancements in treatment options like introduction of biologic therapies, such as anti-TNF agents, anti-integrin agents and JAK inhibitors, rising awareness and diagnosis about disease, personalized medicine approaches, research and development initiatives, collaborations and partnerships between pharmaceutical companies and academic institutions. Johnson and Johnson, AbbVie Inc. (Allergan, Inc.), Merck & Co., Inc., Novartis AG, Bausch Health Companies Inc. are the key global market players in ulcerative colitis market.
France Unresectable Hepatocellular Carcinoma Market Analysis
France Unresectable Hepatocellular Carcinoma Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Unresectable Hepatocellular Carcinoma market is growing globally due to the increasing incidence of unresectable hepatocellular carcinoma which is mainly due to rise in risk factors such as chronic hepatitis B and C infections, alcohol abuse, non-alcoholic fatty liver disease (NAFLD), and obesity. Advancements in diagnostic techniques like imaging techniques and biopsy, introduction of targeted therapies, immunotherapies, rising emphasis on combination therapies, clinical Trials and research initiatives. Bayer AG, Bristol Myers Squibb Company, Eisai Co., Ltd., Exelixis, Inc., Ipsen Pharma, Merck & Co., Inc., Novartis International AG, Roche Holding AG, Sanofi S.A., Takeda Pharmaceutical Company Limited are the key global market players in unresectable hepatocellular carcinoma market.
France Urothelial Carcinoma Market Analysis
France Urothelial Carcinoma Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Urothelial Carcinoma market is growing globally due to the increasing incidence and prevalence of urothelial carcinoma due to aging population, smoking, exposure to certain chemicals, and chronic bladder inflammation, advancements in diagnostic techniques like urinary biomarkers, cystoscopy, development of novel therapies like targeted therapies or immune checkpoint inhibitors and increased focus on personalized medicine. AstraZeneca PLC, Bristol Myers Squibb Company, Eli Lilly and Company, Genentech, Inc. (a member of the Roche Group), Merck & Co., Inc., Novartis AG, Pfizer Inc., Seattle Genetics, Inc., Sanofi S.A., Johnson & Johnson are the key global market players in urothelial carcinoma market.
France Varicella Vaccine Market Analysis
France Varicella Vaccine Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Varicella Vaccine market is growing globally due to the increasing vaccination coverage, growing public awareness about varicella vaccination, well established safety and efficacy profile of varicella vaccine, launch of varicella control programs by various governments. Merck & Co., Inc., GlaxoSmithKline plc, Sanofi Pasteur, Pfizer Inc., Serum Institute of India Pvt. Ltd., Bharat Biotech International Ltd., Changchun BCHT Biotechnology Co., Ltd., Sinovac Biotech Ltd., Kaketsuken (Japan Blood Products Organization) and Shanghai Institute of Biological Products are the key global market players.
France Viscosupplementation Market Analysis
France Viscosupplementation Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Viscosupplementation market is growing globally due to the increasing prevalence of osteoarthritis, growing aging population, and rising awareness about minimally invasive treatment options, increasing awareness and acceptance, technological advancements in viscosupplementation treatments, rise in the healthcare sector spending and infrastructure. Anika Therapeutics, Inc., SEIKAGAKU CORPORATION, Bioventus, Fidia Farmaceutici S.P.A, Ferring B.V, sanofi-aventis U.S. LLC, Zimmer Biomet, OrthogenRx, Inc. (a subsidiary of AVNS), APTISSEN, Johnson & Johnson Services, Inc., LG Chem., Viatris Inc., IBSA Institut Biochimique SA, Ortobrand International, TRB CHEMEDICA SA, Teva Pharmaceutical Industries Ltd., Lifecore (a subsidiary of Landec Corporation), VIRCHOW are the key global market players of viscosupplementation market.
France Vision Care Market Analysis
France Vision Care Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Vision Care market is growing globally due to the increasing prevalence of eye disorders such as myopia, hyperopia, astigmatism, and age-related macular degeneration (AMD), surging volume of patients suffering from chronic diseases which will led to the occurrences of vision ailments, improper intake of nutrition and unhealthy food eating habits, technological advancements in vision care industry like innovations in lens materials, frame designs, and contact lens technologies, increasing awareness about the importance of regular eye exams and eye health initiatives by governments, healthcare organizations and growth of the e-commerce sector. EssilorLuxottica, Johnson & Johnson, Novartis AG (Alcon), CooperVision, Bausch Health Companies (Bausch + Lomb), Zeiss, Hoya Corporation, Safilo Group and Carl Zeiss Meditec are the key global market players.
France Anemia Therapeutics Market Analysis
The France Anemia Therapeutics Market is anticipated to experience a growth from $407 Mn in 2022 to $759 Mn by 2030, with a CAGR of 8.10 % during the forecast period of 2022-2030. Higher prevalence owing to unhealthy lifestyles, initiatives to eliminate societal stigma associated with specific anemias, and improvements in technologies like as gene therapy, gene editing, and innovative medication delivery techniques are among the factors driving market growth. The France Anemia Therapeutics Market encompasses various players across different segments, including Sanofi, Amgen, Novartis, AstraZeneca, Spark Therapeutics, Bluebird Bio, Emmaus Medical, Mylan, Sandoz, Institut Mérieux etc, among various others.
France Antibacterial (Antibiotics) Drugs Market Analysis
France Antibacterial (Antibiotics) Drugs Market is at around $1.4 Bn in 2023 and is projected to reach $1.75 Bn in 2030, exhibiting a CAGR of 3.2% during the forecast period. The market is expanding due to factors such as the prevalence of infectious diseases, improvements in healthcare infrastructure, and rising healthcare expenditures. The market is dominated by key players like Pfizer, AstraZeneca plc, GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Inc., Sanofi S.A., Abbott Laboratories, Novartis AG, Eli Lilly, and Bayer.
France Dermatological Therapeutics Market Analysis
France Dermatological Therapeutics Market is at around $1.12 Bn in 2022 and is projected to reach $1.86 Bn in 2030, exhibiting a CAGR of 7.6% during the forecast period. The market is propelling due to the rising incidence of dermatological conditions, increasing awareness about skin disorders, and growing demand for cosmetic dermatology. The market is dominated by key players like Pierre Fabre (France), Boiron (France), Lallemand Pharma (France), Almirall SA, Pfizer Inc., AbbVie Inc., Amgen Inc., Novartis AG, Gladerma Laboratories, and Bausch Health Companies Inc.
France Alopecia (Hair Loss) Therapeutics Market Analysis
The France Alopecia (Hair Loss) Therapeutics Market was valued at US $226 Mn in 2022, and is predicted to grow at (CAGR) of 6.5% from 2023 to 2030, to US $373 Mn by 2030. The key drivers of this industry include the surge in the prevalence of alopecia (hair loss), increased disposable income, lifestyle changes, and others. The industry is primarily dominated by players such as Johnson & Johnson, Eli Lilly, Merck, Pfizer, Cipla, Sun Pharmaceuticals, and iRestore, among others.
France Digital Therapeutics Market Analysis
France Digital Therapeutics Market is at around $0.17 Bn in 2023 and is projected to reach $0.9 Bn in 2030, exhibiting a CAGR of 26.2% during the forecast period. The market's expansion is being driven by government initiatives and policies, technological advancements, and an aging population. The market is dominated by key players like Mindmaze, Theravance, Voluntis, Omada Health Inc., 2Morrow Inc., Livongo Health Inc., WellDoc, Propeller Health, Canary Health, Noom Inc., Akili Interactive Labs Inc., and HYGIEIA.
France Allergy Therapeutics Market Analysis
France Allergy Therapeutics Market was valued at $638 Mn in 2022 and is estimated to reach $972 Mn in 2030, exhibiting a CAGR of 5.4% during the forecast period. The growing prevalence of allergic disorders and related health issues is driving the demand for allergy treatment pharmaceuticals. The top leading pharmaceutical companies operating in the market are Sanofi, Novartis, GlaxoSmithKline (GSK), AstraZeneca, Merck & Co., Johnson & Johnson, Roche, Teva Pharmaceutical Industries, ALK-Abelló and Stallergenes Greer.
France Alcohol Addiction Therapeutics Market Analysis
The France Alcohol Addiction Therapeutics Market is valued at around $20 Mn in 2022 and is projected to reach $30 Mn by 2030, exhibiting a CAGR of 5.3% during the forecast period. The increasing public awareness of alcoholism, a rising number of cases, and growing government support, including healthcare financing and preventive laws, indicate a shifting societal attitude towards alcohol addiction in France. The key players involved in the research, development, and distribution of Alcohol Addiction Therapeutics in France are Elli Lily, Roche, AbbVie, Lundbeck, Otsuka Pharmaceuticals, Servier, Ipsen, Viatris, and Bioprojet, among various others
France Cardiovascular Drugs Market Analysis
France Cardiovascular Drug Market is at around $3.8 Bn in 2022 and is projected to reach $4.74 Bn in 2030, exhibiting a CAGR of 2.8% during the forecast period. Wider access to cutting-edge, efficient cardiovascular medications is made possible by France's strong healthcare system, which drives market expansion. The market is dominated by key players like Bristol-Myers Squibb Company, Pfizer Inc., Bayer AG, Janssen Pharmaceuticals, Inc., AstraZeneca, Sanofi, Novartis AG, Merck & Co., Inc., Gilead Sciences, Inc., and F. Hoffman-La Roche Ltd.
France Acute Lymphocytic Leukemia (ALL) Therapeutics Market Analysis
The France Acute Lymphocytic Leukemia (ALL) Therapeutics Market was valued at US $91 Mn in 2022, and is predicted to grow at (CAGR) of 6.8% from 2023 to 2030, to US $154 Mn by 2030. The key drivers of this industry include a surge in the incidence of acute lymphocytic Leukemia cases, rising awareness and diagnosis, increased government funding initiatives and other factors. The industry is primarily dominated by players such as Bristol Myers Squibb, Novartis, Sanofi, Pfizer Inc, among other players
France Autosomal Dominant Polycystic Kidney Disease Therapeutics Market Analysis
The France Autosomal Dominant Polycystic Kidney Disease Therapeutics Market was valued at US$30 Mn in 2022 and is predicted to grow at a CAGR of 4.80% from 2023 to 2030, reaching US million by 2030. The key drivers of this industry include the upward trend in the incidence of autosomal dominant polycystic kidney disease, strong healthcare infrastructure and other factors. The industry is primarily dominated by players such as Otsuka, Sanofi, Roche, Biogen, AstraZeneca, Janssen among others
France Age-Related Macular Degeneration Therapeutics Market Analysis
The France Age-Related Macular Degeneration (AMD) Therapeutics Market was valued at US $297 Mn in 2022 and is predicted to grow at a CAGR of 7.90% from 2023 to 2030, to US $546 Mn by 2030. The key drivers of this industry include the upward trend in the prevalence of age-related macular degeneration, increased diagnosis and awareness, and other factors. The industry is primarily dominated by players such as Regeneron Pharmaceuticals, Novartis, Bayer, Roche, and Genetech, among others
France Addiction Therapeutics Market Analysis
France addiction therapeutics market was valued at $278 Mn in 2022 and is estimated to reach $438 Mn in 2030, exhibiting a CAGR of 5.9% during the forecast period. The market for addiction treatments is being driven primarily by the growing recognition and understanding of substance use disorders as a serious public health issue. Major players in the market includes Indivior, Reckitt Benckiser Pharmaceuticals, Sanofi, Ethypharm, Mundipharma, Bioprojet Pharma, GlaxoSmithKline, Pfizer, Novartis and Merck KGaA
France Women's Health Market Analysis
France's Women’s Health Market is projected to grow from $1.098 Bn in 2022 to $1.480 Bn by 2030, registering a CAGR of 3.80% during the forecast period of 2022-30. The France women's health market is expected to grow in the coming years, driven by factors such as an aging population, increased awareness of women's health issues, and government initiatives to promote women's health. There are also many healthcare providers in France, including hospitals, clinics, and private practices, that offer women's health services.
France Vaccines Market Analysis
This report presents a strategic analysis of the France vaccine market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the France vaccine market, offering unmatched value, accuracy, and expert insights.
